Orphan designation: sutimlimab Treatment of immune thrombocytopenia, 28/02/2020 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 11:33

Orphan designation: sutimlimab Treatment of immune thrombocytopenia, 28/02/2020 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2258

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters